.avif)
.avif)
Element Biosciences Email Format
Biotechnology Research
・
201-500 employees
・
San Diego, CA, USA
Element Biosciences is a biotechnology company that develops advanced biological assay systems and sequencing platforms to democratize access to high-quality genomic data for researchers worldwide.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@elembio.com
Company Overview
Industry
Biotechnology Research
Founded
2017
Headquarters
San Diego, CA, USA
Revenue
$25M-$50M
FUNDING Stage
Private
Key Executives
Molly He (CEO, Co-Founder, and Board Member), Logan Zinser (Chief Financial Officer (CFO)), Jeff Labbadia (SVP of Operations)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Element Biosciences?
Element Biosciences uses the first.last@elembio.com format on elementbiosciences.com, so Jane Smith would be jane.smith@elementbiosciences.com.
What sequencing instruments does Element Biosciences offer?
Element Biosciences makes the AVITI, AVITI LT, AVITI24, and the newly introduced VITARI sequencing systems. The AVITI24 is a 5D multiomics platform, while VITARI is designed for high-throughput sequencing at scale.
Who co-founded and leads Element Biosciences?
Molly He is the co-founder and CEO of Element Biosciences. She leads the company alongside CFO Logan Zinser and SVP of Operations Jeff Labbadia from the company's headquarters in San Diego, California.
How many countries use Element Biosciences products?
Element Biosciences has customers in more than 40 countries, and its sequencing platforms have been cited in over 400 publications. Tools like Clay can help identify and reach the right contacts at research institutions already using their systems.
Does Element Biosciences serve the pharma and drug discovery market?
Yes, Element Biosciences has a dedicated pharma focus area, offering multiomic tools that integrate genomics and transcriptomics to support therapeutic discovery. Their AVITI24 platform is specifically suited for single-cell and spatial multiomics applications in drug development.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating